2189.HK
Strong BuyFull HouseAPPROVEKato (Hong Kong) Holdings Limited · Healthcare · Hong Kong · $63M · Avg Vol: $2K/d
Full House: Strong business, sensible price, market agrees. The rare full house.
Company passes all three eligibility legs (>50) and demonstrates alignment through disclosed insider buying. Healthcare stability remains a defensive merit in volatile cycles.
ABOUT KATO (HONG KONG) HOLDINGS LIMITED
Read
Kato (Hong Kong) Holdings Limited, an investment holding company, operates as a residential care home for the elderly in Hong Kong. The company operates in two segments, Elderly Care Services and Investment Properties Holding.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 320.3M | 408.3M | 271.3M | 317.1M | -0.3% | 353.7M |
| EPS (HKD) | 0.10 | 0.13 | 0.06 | 0.02 | -39.5% | 0.03 |
| Shares | 1.0B | 1.0B | 1.0B | 1.0B | 0.0% | 1.0B |
| Debt | 294.8M | 270.0M | 384.3M | 333.0M | 4.1% | 273.6M |
| Equity | 291.5M | 372.6M | 434.3M | 436.8M | 14.4% | — |
| Op CF | 120.8M | 163.1M | 132.4M | 90.9M | -9.0% | 118.7M |
| Inv CF | -82.0M | -55.9M | -236.1M | 9.3M | — | — |
| Fin CF | -95.5M | -87.3M | 69.7M | -86.5M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 2189.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 2189.HK | Kato (Hong Kong) Holdings Limited(you) | $63M | 97 | Strong Buy |
| 2138.HK | EC Healthcare | $61M | 75 | Buy |
| 1830.HK | Perfect Medical Health Management Limited | $210M | 100 | Strong Buy |
| 3309.HK | C-MER Medical Holdings Limited | $129M | 82 | Strong Buy |
| 0648.HK | SoftMedx Healthcare Limited | $83M | 62 | Hold |
| 3886.HK | Town Health International Medical Group Limited | $149M | 47 | Hold |
| 1612.HK | Vincent Medical Holdings Limited | $58M | 92 | Strong Buy |
| 0690.HK | Uni-Bio Science Group Limited | $66M | 84 | Strong Buy |
| 8049.HK | Jilin Province Huinan Changlong Bio-pharmacy Company Limited | $168M | 100 | Strong Buy |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $101M | 84 | Strong Buy |
Peer medians: ROE 6.1% · P/E 10.1x · Gross margin 38.0%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.